2051 - 2060 of 7915 Results
Title
Year
-
OPENTitle: Divergence Between Informant and Self-Ratings of Activities of Daily Living Impairments in Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.838674Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.838674/pdfCitation Count: 3
-
RESTRICTEDTitle: Impact of Surgical History on Parkinson's Disease ProgressionJournal Name: 2022 IEEE Delhi Section Conference (DELCON)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/delcon54057.2022.9753658Citation Count: 0
-
OPENTitle: Trends in the Utilization of Teleneurology and Other Healthcare Resources Prior to and During the COVID-19 Pandemic in an Urban, Tertiary Health SystemJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.834708Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.834708/pdfCitation Count: 6
-
OPENTitle: Semantic Integration of Multi-Modal Data and Derived Neuroimaging Results Using the Platform for Imaging in Precision Medicine (PRISM) in the Arkansas Imaging Enterprise System (ARIES)Journal Name: Frontiers in Artificial IntelligencePublisher: Frontiers Media SAVol: 4Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/frai.2021.649970Best OA location URL: https://www.frontiersin.org/articles/10.3389/frai.2021.649970/pdfCitation Count: 10
-
RESTRICTEDTitle: Special Issue on new therapeutic approaches to Parkinson diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 208Issue #:Start Page: 108998End Page: 108998Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998Citation Count: 3
-
OPENTitle: Assessing Gq-GPCR–induced human astrocyte reactivity using bioengineered neural organoidsJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1083/jcb.202107135Best OA location URL: https://rupress.org/jcb/article-pdf/221/4/e202107135/1428539/jcb_202107135.pdfCitation Count: 12
-
RESTRICTEDTitle: Autonomic and Depression Symptoms in Parkinson’s Disease: Clinical Evidence for Overlapping PhysiologyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 3Start Page: 1059End Page: 1067Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-213075Citation Count: 10
-
OPENTitle: How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 PandemicJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 9Start Page: 801End Page: 801Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2022.1510Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2789055/jama_suran_2022_mn_220006_1645750114.50702.pdfCitation Count: 5
-
OPENTitle: Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 65End Page: 73Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.022Best OA location URL: http://www.prd-journal.com/article/S135380202200030X/pdfCitation Count: 8
-
OPENTitle: Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 166Issue #:Start Page: 105655End Page: 105655Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105655Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105655Citation Count: 47